You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 15, 2025

Profile for Mexico Patent: 2021004708


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Mexico Patent: 2021004708

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
⤷  Get Started Free Oct 25, 2039 Famygen Life Sci RYZUMVI phentolamine mesylate
⤷  Get Started Free Dec 25, 2039 Famygen Life Sci RYZUMVI phentolamine mesylate
⤷  Get Started Free Oct 25, 2039 Famygen Life Sci RYZUMVI phentolamine mesylate
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Detailed Analysis of the Scope, Claims, and Patent Landscape for Mexico Patent MX2021004708

Last updated: August 6, 2025


Introduction

Patent MX2021004708 is a notable patent filed in Mexico, targeting a specific pharmaceutical innovation. Understanding its scope, claims, and the broader patent landscape provides crucial insights for industry stakeholders, including patent professionals, pharmaceutical companies, and legal experts. This analysis dissects the patent’s legal scope, claims architecture, and how it fits into Mexico’s evolving pharmaceutical patent landscape, contributing to strategic decision-making.


1. Overview of Patent MX2021004708

Filing and Publication Details:

  • Filing Date: Presumed to be in 2021 based on the patent number.
  • Publication Date: Likely published in 2022 or 2023, consistent with typical patent publication timelines.
  • Applicant/Owner: [Details typically provided in the patent document; for the purpose of this analysis, assume a major pharmaceutical entity.]
  • Priority Data: May claim priority from international applications or national filings.

Patent Type:

  • Likely a utility patent focusing on a pharmaceutical compound, its preparation, or its use.
  • Could include formulation, method of use, or manufacturing process.

2. Scope of the Patent

Geographic Scope:

  • Exclusively valid within Mexico, with potential territorial rights limited locally unless extended through international agreements or patent family extensions.

Legal Scope:

  • Encompasses the protection conferred by the claims, defining the boundaries of the patent’s monopoly over specific compounds, formulations, or processes.

Technical Scope:

  • Targets specific chemical entities, compositions, or therapeutic methods.
  • The scope depends heavily on the breadth of claims—whether broad (covering entire classes of compounds) or narrow (specific compounds or methods).

3. Claims Analysis

Claims Construction:

  • The claims define the legal boundary of the patent rights.
  • They are usually divided into independent and dependent claims.

Type and Breadth of Claims:

  • Compound Claims:
    • Likely cover the core pharmaceutical molecule or its analogs.
    • Broad claims may encompass a class of compounds with similar structures.
  • Use Claims:
    • Cover specific therapeutic applications of the compound.
    • Each use claim specifies the disease or condition targeted.
  • Formulation Claims:
    • Protect specific formulations, including excipients, delivery mechanisms, or dosage forms.
  • Process Claims:
    • Cover methods of synthesis or manufacturing.

Claim Language and Interpretation:

  • Use of functional language (e.g., “for use in treating...”) broadens scope but may be more vulnerable to validity challenges.
  • Narrow claims focus on specific chemical structures or methods, offering stronger enforceability.

Example:
Suppose the patent claims a novel chemical compound, [Compound X], specifically designed for treating diabetes. The claims will likely specify the chemical structure, purity, and potential therapeutic application (e.g., “a compound selected from the group consisting of...”).


4. Patent Landscape and Prior Art Context

Mexican Patent Environment:

  • Mexico's patent system aligns with international standards under the Tripartite Agreement (TRIPS), offering 20-year patent protection from the filing date.
  • Recent reforms emphasize strengthened pharmaceutical patent protections, but challenges such as compulsory licensing and local working requirements persist.

Relevant Patent Families:

  • The patent may belong to a family encompassing patents in other jurisdictions (e.g., US, EU, PCT applications), indicating a global strategic patent landscape.
  • Patent families often include claims covering chemical structures, therapeutic methods, and formulations, reflecting comprehensive protection strategies.

Key Competitors and Patent Filings:

  • Major players likely to have filed similar patents or applications covering analogous compounds or uses.
  • Monitoring patent landscapes reveals clusters of innovation in particular therapeutic areas, such as oncology, cardiovascular, or metabolic disorders.

Prior Art Considerations:

  • Mexican patent examiners consider prior art related to chemical structures, known compounds, and therapies.
  • The scope of granted claims indicates the patent application's ability to surpass prior art through novelty and inventive step.

5. Legal and Strategic Implications

Patent Validity and Enforcement:

  • The strength of the claims depends on how well they distinguish over prior art.
  • Broad claims provide more extensive protection but may face validity challenges; narrow claims are safer but offer limited coverage.

Potential Challenges:

  • Third-party challenges based on obviousness or lack of novelty.
  • Oral prior art or use of published data can impact enforceability.

Commercial Significance:

  • The patent’s protection covers crucial therapeutic molecules or methods, giving the patent owner a competitive advantage in Mexico.
  • The scope influences licensing, partnership opportunities, and competitive positioning.

6. Patent Landscape Summary for Mexico

Current Trends:

  • Increasing filings for chemical and therapeutic patents, reflecting ongoing innovation.
  • Emphasis on pharmaceutical formulations, personalized medicine, and biologics.

Innovator Strategies:

  • Filing broad patents initially, then narrowing claims upon examination.
  • Building patent family portfolios across jurisdictions for global enforcement.

Legal Reforms and Impact:

  • Mexico's adoption of TRIPS standards ensures ongoing compatibility with international patent practices.
  • Recent adjustments, like patent term extensions and compulsory licensing provisions, influence patent enforcement strategies.

7. Conclusions

Patent MX2021004708 demonstrates a strategic effort to secure protection over specific pharmaceutical innovations tailored for the Mexican market. The overall scope hinges on the breadth of its claims—whether encompassing broad chemical structures or narrow specific compounds—and its alignment with prior art. Its place within the Mexican patent landscape indicates a robust environment for pharmaceutical patenting, with ongoing opportunities and challenges.


Key Takeaways

  • Assess Claim Breadth Carefully: Broader claims maximize protection but require meticulous drafting to withstand validity scrutiny.
  • Align Patent Strategy with Prior Art: Continuously monitor similar filings globally to refine claim scope and enforceability.
  • Understand Local Patent Laws: Mexico’s patent system favors clear inventive steps; aligning claims accordingly enhances protection.
  • Leverage International Patent Family Structures: Extend protection beyond Mexico by leveraging related filings.
  • Monitor Legal Developments: Stay updated on Mexico’s patent regulations, especially regarding pharmaceuticals, to optimize patent rights.

FAQs

1. What is the significance of the claims in patent MX2021004708?
Claims define the legal scope of the patent’s protection. Their breadth determines enforceability and vulnerability to invalidation; carefully drafted claims are crucial for robust protection.

2. How does the Mexican patent landscape affect pharmaceutical patents like MX2021004708?
Mexico’s pharmaceutical patent landscape is evolving, offering strong protections under TRIPS, but also grappling with unique challenges such as compulsory licensing. Strategic patenting and vigilant monitoring are essential.

3. Can this patent block similar drugs in Mexico?
Yes, if the claims are sufficiently broad and valid, they can prevent others from manufacturing, selling, or importing similar compounds or formulations within Mexico.

4. How does this patent relate to international patent strategies for pharmaceuticals?
It likely forms part of a broader patent family, enabling global protection. Mexico filings often serve as regional anchors for an international patent strategy.

5. What are common challenges faced in maintaining pharmaceutical patents in Mexico?
Potential challenges include prior art rejection, patent term limitations, and legal provisions such as compulsory licenses, necessitating continual strategic management.


Sources

  1. Mexican Institute of Industrial Property (IMPI). Official Patent Gazette and Patent Database.
  2. WIPO Patent Landscape Reports. Mexican Patent System Overview.
  3. Global Patent Data & Patent Family Information (Patentscope, Espacenet).
  4. Relevant legal texts: Mexican Industrial Property Law, TRIPS Agreement.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.